Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece
<p>Abstract</p> <p>Background</p> <p>Health Related Quality of Life (HRQoL) is an important outcome measure in Inflammatory Bowel Disease (IBD). The aim of our study was to assess HRQoL in a population of 135 Greek patients with IBD.</p> <p>Methods</p>...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2002-01-01
|
| Series: | BMC Gastroenterology |
| Online Access: | http://www.biomedcentral.com/1471-230X/2/1 |
| _version_ | 1818833801548136448 |
|---|---|
| author | Mouzas Ioannis A Vlachonikolis Ioannis G Pallis Athanasios G |
| author_facet | Mouzas Ioannis A Vlachonikolis Ioannis G Pallis Athanasios G |
| author_sort | Mouzas Ioannis A |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Health Related Quality of Life (HRQoL) is an important outcome measure in Inflammatory Bowel Disease (IBD). The aim of our study was to assess HRQoL in a population of 135 Greek patients with IBD.</p> <p>Methods</p> <p>A cohort of 135 patients with IBD, 81 with ulcerative colitis (UC) and 54 with Crohn's disease (CD) were enrolled in our study. Demographic and disease-related data were recorded. HRQoL was assessed by a disease-specific and a generic questionnaire, IBDQ and SF-36, respectively. Disease activity was assessed by Harvey-Bradshaw Index and the Colitis Activity Index for CD and UC patients, respectively.</p> <p>Results</p> <p>Among all variables recorded in our study, only disease activity had a significant effect on HRQoL. Patients with active disease scored significantly lower on both IBDQ and SF-36 when compared to those in remission. Only two among the four IBDQ dimensions, bowel and systemic, had significant ability in distinguishing best patients in remission from those with active disease.</p> <p>Conclusions</p> <p>IBD has a negative impact on HRQoL. Patients with active disease are more impaired than patients in remission. In our population of patients bowel and systemic dimensions had a predominant value in patients' perception of quality of life. Patients in our study using the same instrument scored higher than previously reported.</p> |
| first_indexed | 2024-12-19T02:24:42Z |
| format | Article |
| id | doaj.art-b0969234fefe4c889f460f1a28f1ffd3 |
| institution | Directory Open Access Journal |
| issn | 1471-230X |
| language | English |
| last_indexed | 2024-12-19T02:24:42Z |
| publishDate | 2002-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Gastroenterology |
| spelling | doaj.art-b0969234fefe4c889f460f1a28f1ffd32022-12-21T20:39:58ZengBMCBMC Gastroenterology1471-230X2002-01-0121110.1186/1471-230X-2-1Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, GreeceMouzas Ioannis AVlachonikolis Ioannis GPallis Athanasios G<p>Abstract</p> <p>Background</p> <p>Health Related Quality of Life (HRQoL) is an important outcome measure in Inflammatory Bowel Disease (IBD). The aim of our study was to assess HRQoL in a population of 135 Greek patients with IBD.</p> <p>Methods</p> <p>A cohort of 135 patients with IBD, 81 with ulcerative colitis (UC) and 54 with Crohn's disease (CD) were enrolled in our study. Demographic and disease-related data were recorded. HRQoL was assessed by a disease-specific and a generic questionnaire, IBDQ and SF-36, respectively. Disease activity was assessed by Harvey-Bradshaw Index and the Colitis Activity Index for CD and UC patients, respectively.</p> <p>Results</p> <p>Among all variables recorded in our study, only disease activity had a significant effect on HRQoL. Patients with active disease scored significantly lower on both IBDQ and SF-36 when compared to those in remission. Only two among the four IBDQ dimensions, bowel and systemic, had significant ability in distinguishing best patients in remission from those with active disease.</p> <p>Conclusions</p> <p>IBD has a negative impact on HRQoL. Patients with active disease are more impaired than patients in remission. In our population of patients bowel and systemic dimensions had a predominant value in patients' perception of quality of life. Patients in our study using the same instrument scored higher than previously reported.</p>http://www.biomedcentral.com/1471-230X/2/1 |
| spellingShingle | Mouzas Ioannis A Vlachonikolis Ioannis G Pallis Athanasios G Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece BMC Gastroenterology |
| title | Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece |
| title_full | Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece |
| title_fullStr | Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece |
| title_full_unstemmed | Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece |
| title_short | Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece |
| title_sort | assessing health related quality of life in patients with inflammatory bowel disease in crete greece |
| url | http://www.biomedcentral.com/1471-230X/2/1 |
| work_keys_str_mv | AT mouzasioannisa assessinghealthrelatedqualityoflifeinpatientswithinflammatoryboweldiseaseincretegreece AT vlachonikolisioannisg assessinghealthrelatedqualityoflifeinpatientswithinflammatoryboweldiseaseincretegreece AT pallisathanasiosg assessinghealthrelatedqualityoflifeinpatientswithinflammatoryboweldiseaseincretegreece |